Latest filing published 12 Nov 2021 for Fulcrum Therapeutics, Inc..
Filing timeline
BuySaleFirst 200 filings with a declared amount
Insider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Mark J. Levin: trading record in brief
This profile gathers the share dealings of Mark J. Levin across 5 companies, led by Millennium Pharmaceuticals Inc, Foundation Medicine, Inc. and Voyager Therapeutics, Inc. Over a trading history stretching from 8 February 2007 to 10 November 2021, the count stands at 962 filings.
Market trades split into 1 purchase (€1.2M) and 944 sales (€4.5M). Sales outweigh purchases by €3.4M. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The latest filing, published on 12 November 2021, reports a transaction in Fulcrum Therapeutics, Inc. The clock since the last published purchase (22 July 2019) now reads 2,666 days. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Mark J. Levin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,000,000 sharesCommon StockSEC:0000899243-21-044427:0
- 1,000,000 sharesCommon StockSEC:0000899243-21-037615:0
- 5,595,238 sharesCommon StockSEC:0001104659-19-041304:0
- 81,250 shares@ US$16.00100.0% of flowCommon StockSEC:0001104659-19-041304:1Canonical exit: 20 Oct 2019 (T+90)
- 1,500,000 sharesCommon StockSEC:0000899243-18-024774:0
- 1,500,000 sharesCommon StockSEC:0000899243-18-017586:0
- 920,000 sharesCommon StockSEC:0000899243-17-010310:0
- 24,800 shares@ US$40.7482.4% of flowCommon StockSEC:0000899243-17-008208:0
- 5,200 shares@ US$41.5517.6% of flowCommon StockSEC:0000899243-17-008208:1
- 750,000 sharesCommon StockSEC:0000899243-16-036196:0
- 10,588,235 sharesCommon StockSEC:0001104659-15-079932:0
- 1,642,411 shares0Common StockSEC:0001012975-14-000271:0
- 120,577 shares0Common StockSEC:0001012975-14-000271:1
- 120,577 shares0Common StockSEC:0001012975-14-000271:2
- 17,462 shares0Common StockSEC:0001012975-14-000271:3
- 5,943,097 sharesCommon StockSEC:0001181431-13-052110:0
- 276,548 sharesCommon StockSEC:0001181431-13-052110:1
- 2,264,224 shares@ US$25.00Common StockSEC:0001179110-08-009459:0
- 400,000 shares0Common StockSEC:0001180428-08-000010:0
- 400,000 shares0Common StockSEC:0001180428-08-000010:1
- 100 shares@ US$15.47Common stockSEC:0001180428-08-000008:0
- 100 shares@ US$15.42Common stockSEC:0001180428-08-000008:1
- 100 shares@ US$15.40Common stockSEC:0001180428-08-000008:2
- 100 shares@ US$15.21Common stockSEC:0001180428-08-000008:3
- 300 shares@ US$15.01Common stockSEC:0001180428-08-000008:4
25 of 960 declarations
